• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    life science investing

    Canada in Need of Rare Disease Strategy

    Vivien Diniz
    Jan. 20, 2016 09:18AM PST
    Life Science Investing News

    Canadian Organization for Rare Disorders reported that most of the 2.8 million Canadians with a rare disease experience extraordinary and unnecessary barriers getting the right diagnosis, specialist, and treatment.

    Canadian Organization for Rare Disorders reported that most of the 2.8 million Canadians with a rare disease experience extraordinary and unnecessary barriers getting the right diagnosis, specialist, and treatment. As such, Canadian Organization for Rare Disorders (CORD) and the Economic Club of Canada convened a panel calling for the immediate implementation of Canada’s Rare Disease Strategy.
    According Durhane Wong-Rieger, President and CEO of CORD:

    We have crafted a Strategy that is both ambitious and achievable. Canadian strategies for cancer, heart disease, and diabetes have significantly improved quality and longevity of life. More than 30 other countries have national rare disease plans. With respect to drugs for rare diseases, patients have been waiting for over a decade for the national plan that was promised by Health Ministers in 2005. But we are hopeful that these Health Ministers will announce concrete steps towards fulfilling that commitment.

    Click here to view the full release.
     

    rare diseaseslife science investingcanadarare disease
    The Conversation (0)

    Go Deeper

    AI Powered
    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Canada maple leaves on left and pharmaceutical pills in red and blue on right.

    5 Best-performing Canadian Pharma Stocks of 2025

    Latest News

    Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027

    Funded Collaboration Agreement with Protect Animal Health

    Canadian Investment Regulatory Organization Trade Resumption - CRDL

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing News Stocks

    Defence Therapeutics Class A

    DTC:CC

    Cloud DX

    CDX:CA

    BioHarvest Sciences

    BHSC:CNX

    Billy Goat Brands

    GOAT:CC

    Contakt World

    HELP:CNX
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES